NCT01164709 2019-05-15Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerSwiss Cancer InstitutePhase 1 Completed18 enrolled
NCT00671112 2015-10-28Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaCase Comprehensive Cancer CenterPhase 1 Terminated30 enrolled
NCT01129180 2013-12-03Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell LymphomaOhio State University Comprehensive Cancer CenterPhase 1 Completed8 enrolled